Biotechnology
The Biotechnology industry has a total of 606 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.47 billion.
Market Cap
1.12T
Revenue
105.47B
Profits
-42.14B
PE Ratio
n/a
Profit Margin
-39.95%
Dividend Yield
0.04%
606 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.65B | -0.67% | 628,161 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.08B | -0.57% | 525,994 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 52.69B | -0.44% | 636,817 | 3.21B |
| 4 | ARGX | argenx SE | 51.51B | -0.88% | 158,790 | 3.68B |
| 5 | INSM | Insmed Incorporated | 37.61B | -0.87% | 2,458,962 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 34.34B | -0.67% | 215,261 | 4.97B |
| 7 | BNTX | BioNTech SE | 22.89B | 0.72% | 462,751 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.56B | -0.36% | 1,628,066 | 2.35B |
| 9 | GMAB | Genmab A/S | 20.17B | -2.69% | 1,499,106 | 3.85B |
| 10 | INCY | Incyte Corporation | 19.49B | -0.82% | 1,153,762 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.57B | -0.28% | 1,798,127 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 15.09B | -2.38% | 5,029,109 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.57B | -0.25% | 1,366,227 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.71B | -1.98% | 1,879,819 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.39B | -1.58% | 217,298 | 740.64M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.95B | 0.06% | 1,070,081 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.89B | 0.98% | 291,201 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 12.21B | -1.88% | 1,825,235 | 2.29B |
| 19 | MRNA | Moderna, Inc. | 12.17B | -0.16% | 5,923,222 | 2.23B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.53B | 0.15% | 1,362,381 | 3.09B |
| 21 | ABVX | ABIVAX Société Anonyme | 11.20B | -1.34% | 891,232 | 6.23M |
| 22 | RNA | Avidity Biosciences, Inc. | 10.87B | 0.06% | 588,617 | 20.87M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.36B | 0.01% | 522,333 | 4.16B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.46B | -0.77% | 893,968 | 829.45M |
| 25 | TECH | Bio-Techne Corporation | 9.23B | 0.03% | 753,598 | 1.22B |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.40B | -3.42% | 913,810 | 741.17M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.11B | 0.12% | 949,845 | 1.24B |
| 28 | NUVL | Nuvalent, Inc. | 7.90B | -2.24% | 227,197 | - |
| 29 | CAI | Caris Life Sciences, Inc. | 7.89B | -1.01% | 1,192,434 | 649.06M |
| 30 | PRAX | Praxis Precision Medicines, Inc. | 7.62B | 13.25% | 1,593,426 | 7.46M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 7.60B | -0.90% | 452,862 | 561.26M |
| 32 | CYTK | Cytokinetics, Incorporated | 7.55B | -2.15% | 1,702,111 | 87.21M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.51B | 2.32% | 580,165 | 174.33M |
| 34 | KRYS | Krystal Biotech, Inc. | 7.36B | 0.60% | 180,486 | 373.16M |
| 35 | CDTX | Cidara Therapeutics, Inc. | 6.94B | -0.18% | 1,268,888 | 302.00K |
| 36 | MRUS | Merus N.V. | 6.83B | -7.14% | 2,723,052 | 56.61M |
| 37 | KYMR | Kymera Therapeutics, Inc. | 6.43B | -1.19% | 766,744 | 43.74M |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.23B | -1.17% | 841,974 | 1.78B |
| 39 | BLTE | Belite Bio, Inc | 6.20B | 6.69% | 309,240 | - |
| 40 | PCVX | Vaxcyte, Inc. | 6.10B | -0.85% | 743,222 | - |
| 41 | COGT | Cogent Biosciences, Inc. | 5.77B | -2.47% | 1,027,916 | - |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 5.50B | -0.96% | 365,643 | 209.22M |
| 43 | IMVT | Immunovant, Inc. | 5.19B | -2.10% | 1,524,276 | - |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.15B | -1.22% | 1,161,223 | - |
| 45 | CRSP | CRISPR Therapeutics AG | 5.14B | -2.02% | 1,276,748 | 38.34M |
| 46 | CELC | Celcuity Inc. | 4.70B | -0.68% | 631,767 | - |
| 47 | GPCR | Structure Therapeutics Inc. | 4.66B | -1.40% | 384,266 | - |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 4.61B | -1.30% | 981,946 | 1.05B |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.61B | -1.05% | 651,101 | - |
| 50 | ADMA | ADMA Biologics, Inc. | 4.55B | -0.88% | 1,069,316 | 488.56M |
| 51 | TERN | Terns Pharmaceuticals, Inc. | 4.51B | -0.05% | 1,780,470 | - |
| 52 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.51B | -0.92% | 542,255 | 1.54M |
| 53 | TGTX | TG Therapeutics, Inc. | 4.46B | -0.78% | 1,210,146 | 531.90M |
| 54 | FOLD | Amicus Therapeutics, Inc. | 4.40B | - | 8,125,132 | 598.70M |
| 55 | MIRM | Mirum Pharmaceuticals, Inc. | 4.12B | 1.20% | 460,734 | 471.79M |
| 56 | VKTX | Viking Therapeutics, Inc. | 4.12B | -1.94% | 1,871,187 | - |
| 57 | LEGN | Legend Biotech Corporation | 4.05B | -2.71% | 2,793,529 | 909.05M |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 3.97B | -0.71% | 368,187 | 35.24M |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 3.84B | -0.34% | 97,074 | 251.23M |
| 60 | ACLX | Arcellx, Inc. | 3.77B | -0.84% | 407,823 | 35.90M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.71B | -2.48% | 1,363,194 | - |
| 62 | CNTA | Centessa Pharmaceuticals plc | 3.62B | -2.13% | 283,744 | 15.00M |
| 63 | ARQT | Arcutis Biotherapeutics, Inc. | 3.50B | -1.42% | 1,340,841 | 317.93M |
| 64 | TARS | Tarsus Pharmaceuticals, Inc. | 3.48B | 0.23% | 405,294 | 366.10M |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.48B | -1.92% | 1,351,288 | 435.83M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.43B | -1.14% | 581,481 | 7.50M |
| 67 | WVE | Wave Life Sciences Ltd. | 3.27B | 0.51% | 2,161,230 | 109.23M |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.23B | -2.20% | 2,231,650 | - |
| 69 | CGON | CG Oncology, Inc. | 3.22B | 0.05% | 542,702 | 2.17M |
| 70 | APLS | Apellis Pharmaceuticals, Inc. | 3.18B | 0.80% | 2,256,505 | 1.02B |
| 71 | NUVB | Nuvation Bio Inc. | 3.11B | -3.62% | 6,940,054 | 26.75M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | -1.02% | 514,490 | 214.83M |
| 73 | LQDA | Liquidia Corporation | 3.02B | 0.99% | 813,510 | 69.22M |
| 74 | VRDN | Viridian Therapeutics, Inc. | 3.01B | -1.07% | 820,914 | 70.79M |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.96B | -1.19% | 649,303 | 578.20M |
| 76 | IRON | Disc Medicine, Inc. | 2.96B | -2.54% | 377,638 | - |
| 77 | MLYS | Mineralys Therapeutics, Inc. | 2.91B | -0.83% | 994,489 | - |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.89B | 1.04% | 957,648 | 240.00M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.75B | -0.50% | 1,469,058 | 55.70M |
| 80 | TLX | Telix Pharmaceuticals Limited | 2.67B | -2.37% | 384,816 | 664.23M |
| 81 | OCUL | Ocular Therapeutix, Inc. | 2.62B | -2.07% | 2,078,007 | 55.78M |
| 82 | EWTX | Edgewise Therapeutics, Inc. | 2.61B | -6.57% | 1,601,085 | - |
| 83 | DNLI | Denali Therapeutics Inc. | 2.59B | -1.72% | 1,263,370 | - |
| 84 | SLNO | Soleno Therapeutics, Inc. | 2.55B | -0.21% | 827,468 | 98.68M |
| 85 | ADPT | Adaptive Biotechnologies Corporation | 2.54B | -0.30% | 2,236,680 | 252.75M |
| 86 | SYRE | Spyre Therapeutics, Inc. | 2.53B | -1.15% | 348,264 | - |
| 87 | AAPG | Ascentage Pharma Group International | 2.44B | -6.36% | 5,661 | 54.52M |
| 88 | MESO | Mesoblast Limited | 2.41B | -2.77% | 145,303 | 17.20M |
| 89 | SRPT | Sarepta Therapeutics, Inc. | 2.29B | -1.36% | 2,666,629 | 2.41B |
| 90 | HRMY | Harmony Biosciences Holdings, Inc. | 2.18B | -0.58% | 387,993 | 825.94M |
| 91 | GLPG | Galapagos NV | 2.17B | 0.33% | 104,265 | 336.64M |
| 92 | RXRX | Recursion Pharmaceuticals, Inc. | 2.15B | -2.82% | 24,521,392 | 43.69M |
| 93 | ZBIO | Zenas BioPharma, Inc. | 2.10B | -8.10% | 155,993 | 15.00M |
| 94 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -2.22% | 679,929 | 265.81M |
| 95 | OLMA | Olema Pharmaceuticals, Inc. | 2.02B | -2.25% | 1,009,572 | - |
| 96 | IBRX | ImmunityBio, Inc. | 2.01B | -4.67% | 12,070,342 | 82.56M |
| 97 | ZYME | Zymeworks Inc. | 2.00B | -0.48% | 387,211 | 134.48M |
| 98 | ZLAB | Zai Lab Limited | 1.98B | -2.78% | 520,864 | 441.63M |
| 99 | IMNM | Immunome, Inc. | 1.98B | -0.51% | 2,123,118 | 9.68M |
| 100 | NRIX | Nurix Therapeutics, Inc. | 1.96B | 0.31% | 818,194 | 83.69M |
| 101 | MAZE | Maze Therapeutics, Inc. | 1.95B | -3.68% | 424,620 | 2.50M |
| 102 | SION | Sionna Therapeutics, Inc. | 1.91B | -2.04% | 133,581 | - |
| 103 | VCEL | Vericel Corporation | 1.90B | -0.19% | 456,157 | 258.72M |
| 104 | RARE | Ultragenyx Pharmaceutical Inc. | 1.90B | -42.32% | 21,674,847 | 630.60M |
| 105 | STOK | Stoke Therapeutics, Inc. | 1.84B | 0.81% | 315,344 | 205.63M |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | -1.08% | 668,443 | 111.30M |
| 107 | IMCR | Immunocore Holdings plc | 1.78B | -2.27% | 325,639 | 379.59M |
| 108 | DNTH | Dianthus Therapeutics, Inc. | 1.78B | -0.62% | 276,177 | 3.08M |
| 109 | MNKD | MannKind Corporation | 1.77B | -0.35% | 1,610,030 | 313.79M |
| 110 | CLDX | Celldex Therapeutics, Inc. | 1.73B | -1.40% | 489,410 | 2.60M |
| 111 | PHVS | Pharvaris N.V. | 1.67B | -0.08% | 122,073 | - |
| 112 | TRVI | Trevi Therapeutics, Inc. | 1.64B | -0.27% | 798,126 | - |
| 113 | FTRE | Fortrea Holdings Inc. | 1.59B | -0.86% | 656,439 | 2.76B |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.58B | -3.07% | 1,019,802 | 44.79M |
| 115 | PGEN | Precigen, Inc. | 1.57B | 6.97% | 6,303,103 | 6.31M |
| 116 | UPB | Upstream Bio, Inc. | 1.56B | -2.20% | 238,317 | 2.80M |
| 117 | CAPR | Capricor Therapeutics, Inc. | 1.55B | 1.18% | 917,229 | 11.13M |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.55B | -3.09% | 1,637,542 | 6.31M |
| 119 | BHVN | Biohaven Ltd. | 1.53B | 3.50% | 3,977,120 | - |
| 120 | QURE | uniQure N.V. | 1.53B | -1.01% | 1,014,518 | 15.75M |
| 121 | KOD | Kodiak Sciences Inc. | 1.52B | -3.61% | 1,293,348 | - |
| 122 | SVRA | Savara Inc. | 1.52B | -2.09% | 1,012,508 | - |
| 123 | EYPT | EyePoint, Inc. | 1.51B | -0.49% | 697,789 | 42.34M |
| 124 | ORKA | Oruka Therapeutics, Inc. | 1.50B | -2.52% | 437,238 | - |
| 125 | INVA | Innoviva, Inc. | 1.48B | -0.35% | 553,433 | 388.52M |
| 126 | RLAY | Relay Therapeutics, Inc. | 1.46B | -1.75% | 1,335,593 | 8.36M |
| 127 | ATAI | Atai Beckley N.V. | 1.45B | -1.72% | 2,572,661 | 3.02M |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.44B | 0.17% | 172,842 | - |
| 129 | ANAB | AnaptysBio, Inc. | 1.41B | 1.62% | 438,142 | 169.47M |
| 130 | ARDX | Ardelyx, Inc. | 1.40B | 0.70% | 2,040,198 | 398.23M |
| 131 | MBX | MBX Biosciences, Inc. | 1.40B | 0.55% | 364,363 | - |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.36B | -1.85% | 345,603 | - |
| 133 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.34B | -1.14% | 1,018,921 | -665.00K |
| 134 | MNMD | Mind Medicine (MindMed) Inc. | 1.33B | 3.06% | 1,137,299 | - |
| 135 | SEPN | Septerna, Inc. | 1.27B | -0.80% | 124,132 | 22.05M |
| 136 | XERS | Xeris Biopharma Holdings, Inc. | 1.23B | 0.81% | 1,382,539 | 266.14M |
| 137 | IMTX | Immatics N.V. | 1.23B | -0.88% | 176,207 | 99.45M |
| 138 | PHAT | Phathom Pharmaceuticals, Inc. | 1.20B | -1.94% | 433,175 | 147.19M |
| 139 | PVLA | Palvella Therapeutics, Inc. | 1.20B | -2.15% | 175,016 | - |
| 140 | TNGX | Tango Therapeutics, Inc. | 1.18B | 0.92% | 2,293,032 | 66.50M |
| 141 | OMER | Omeros Corporation | 1.17B | 5.47% | 5,526,012 | - |
| 142 | SPRY | ARS Pharmaceuticals, Inc. | 1.16B | 2.99% | 1,173,235 | 142.77M |
| 143 | OCS | Oculis Holding AG | 1.16B | -2.44% | 33,799 | 992.00K |
| 144 | INBX | Inhibrx Biosciences, Inc. | 1.15B | -1.17% | 138,141 | 1.40M |
| 145 | PHAR | Pharming Group N.V. | 1.15B | -3.99% | 58,165 | 362.27M |
| 146 | NVAX | Novavax, Inc. | 1.11B | -0.15% | 2,896,328 | 1.06B |
| 147 | IOVA | Iovance Biotherapeutics, Inc. | 1.11B | -2.11% | 8,849,704 | 250.43M |
| 148 | SANA | Sana Biotechnology, Inc. | 1.10B | -6.58% | 2,797,100 | - |
| 149 | NBTX | Nanobiotix S.A. | 1.09B | -2.39% | 38,003 | 11.93M |
| 150 | URGN | UroGen Pharma Ltd. | 1.09B | 1.30% | 460,617 | 96.52M |
| 151 | ALMS | Alumis Inc. | 1.09B | -4.74% | 578,794 | 22.12M |
| 152 | XNCR | Xencor, Inc. | 1.08B | -0.33% | 438,849 | 150.13M |
| 153 | NTLA | Intellia Therapeutics, Inc. | 1.06B | -3.18% | 4,003,299 | 57.53M |
| 154 | GLUE | Monte Rosa Therapeutics, Inc. | 1.05B | -6.77% | 951,943 | 181.54M |
| 155 | ABCL | AbCellera Biologics Inc. | 1.04B | -3.35% | 2,715,381 | 35.33M |
| 156 | MDXG | MiMedx Group, Inc. | 1.02B | 0.14% | 819,582 | 393.44M |
| 157 | CRMD | CorMedix Inc. | 1.00B | 1.60% | 2,159,950 | 214.30M |
| 158 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 995.06M | 0.89% | 146,459 | - |
| 159 | RAPT | RAPT Therapeutics, Inc. | 993.16M | 1.19% | 413,751 | - |
| 160 | ERAS | Erasca, Inc. | 981.64M | -0.57% | 1,613,295 | - |
| 161 | MLTX | MoonLake Immunotherapeutics | 977.46M | -0.98% | 950,704 | - |
| 162 | CVAC | CureVac N.V. | 972.78M | 0.47% | 639,412 | 83.00M |
| 163 | DAWN | Day One Biopharmaceuticals, Inc. | 962.07M | -0.85% | 710,065 | 133.67M |
| 164 | TBPH | Theravance Biopharma, Inc. | 948.08M | -0.69% | 246,886 | 80.33M |
| 165 | ELVN | Enliven Therapeutics, Inc. | 946.89M | -2.12% | 376,446 | - |
| 166 | CMPX | Compass Therapeutics, Inc. | 915.99M | -0.39% | 689,533 | 850.00K |
| 167 | KURA | Kura Oncology, Inc. | 909.33M | -1.69% | 1,061,651 | 104.03M |
| 168 | ABUS | Arbutus Biopharma Corporation | 907.77M | -1.26% | 542,056 | 14.61M |
| 169 | BCAX | Bicara Therapeutics Inc. | 904.45M | -1.73% | 356,943 | - |
| 170 | IVA | Inventiva S.A. | 878.54M | 1.56% | 88,820 | 19.93M |
| 171 | GERN | Geron Corporation | 874.55M | - | 4,592,843 | 183.40M |
| 172 | AVBP | ArriVent BioPharma, Inc. | 873.10M | -3.73% | 253,751 | - |
| 173 | NKTR | Nektar Therapeutics | 869.20M | -3.96% | 768,375 | 62.60M |
| 174 | YDES | YD Bio Limited | 862.61M | 0.22% | 12,567 | 510.36K |
| 175 | MRVI | Maravai LifeSciences Holdings, Inc. | 852.78M | 1.99% | 989,711 | 192.44M |
| 176 | JANX | Janux Therapeutics, Inc. | 846.28M | -1.26% | 2,090,083 | 10.00M |
| 177 | VIR | Vir Biotechnology, Inc. | 831.97M | -0.33% | 1,112,848 | 16.86M |
| 178 | ORIC | ORIC Pharmaceuticals, Inc. | 804.44M | 0.12% | 1,004,992 | - |
| 179 | FULC | Fulcrum Therapeutics, Inc. | 790.98M | 3.54% | 1,155,287 | 80.00M |
| 180 | GHRS | GH Research PLC | 781.57M | - | 140,227 | - |
| 181 | RIGL | Rigel Pharmaceuticals, Inc. | 781.23M | -2.20% | 730,764 | 282.08M |
| 182 | MPLT | MapLight Therapeutics, Inc. | 774.20M | -1.50% | 92,782 | - |
| 183 | KALV | KalVista Pharmaceuticals, Inc. | 766.79M | - | 410,926 | 1.43M |
| 184 | REPL | Replimune Group, Inc. | 765.61M | -2.01% | 1,198,037 | - |
| 185 | LYEL | Lyell Immunopharma, Inc. | 764.92M | 2.74% | 113,821 | 41.00K |
| 186 | ARVN | Arvinas, Inc. | 764.27M | -2.14% | 568,352 | 312.30M |
| 187 | VALN | Valneva SE | 761.59M | 4.88% | 25,448 | 211.09M |
| 188 | LXEO | Lexeo Therapeutics, Inc. | 749.58M | 0.20% | 467,407 | - |
| 189 | JBIO | Jade Biosciences, Inc. | 746.19M | -1.40% | 236,691 | - |
| 190 | ANNX | Annexon, Inc. | 745.28M | -2.15% | 1,346,430 | - |
| 191 | GOSS | Gossamer Bio, Inc. | 742.97M | -0.62% | 4,111,163 | 44.05M |
| 192 | ATXS | Astria Therapeutics, Inc. | 741.53M | 0.31% | 284,931 | 706.00K |
| 193 | RGNX | REGENXBIO Inc. | 723.91M | 0.99% | 789,009 | 161.32M |
| 194 | CTMX | CytomX Therapeutics, Inc. | 709.93M | -4.56% | 1,738,719 | 113.63M |
| 195 | DBVT | DBV Technologies S.A. | 698.43M | 1.83% | 350,480 | 5.50M |
| 196 | DRUG | Bright Minds Biosciences Inc. | 671.82M | -4.87% | 141,812 | - |
| 197 | PROK | ProKidney Corp. | 661.84M | -13.04% | 1,505,536 | 744.00K |
| 198 | GYRE | Gyre Therapeutics, Inc. | 649.41M | -1.58% | 41,118 | 107.27M |
| 199 | VTYX | Ventyx Biosciences, Inc. | 647.94M | -1.94% | 648,276 | - |
| 200 | MGTX | MeiraGTx Holdings plc | 629.44M | -1.88% | 287,511 | 27.42M |
| 201 | KROS | Keros Therapeutics, Inc. | 628.52M | -1.90% | 247,774 | 246.72M |
| 202 | NBY | NovaBay Pharmaceuticals, Inc. | 612.41M | 0.21% | 422,563 | 10.30M |
| 203 | ENGN | enGene Holdings Inc. | 605.54M | -4.84% | 116,217 | - |
| 204 | IVVD | Invivyd, Inc. | 603.79M | -3.72% | 1,801,109 | 50.04M |
| 205 | CGEM | Cullinan Therapeutics, Inc. | 599.03M | -2.22% | 801,991 | - |
| 206 | VSTM | Verastem, Inc. | 598.93M | -3.72% | 1,019,688 | 13.38M |
| 207 | PRME | Prime Medicine, Inc. | 596.62M | -3.71% | 2,917,584 | 5.98M |
| 208 | ANRO | Alto Neuroscience, Inc. | 576.90M | 0.76% | 277,201 | - |
| 209 | EVMN | Evommune, Inc. | 567.43M | 4.59% | 321,424 | 13.00M |
| 210 | DSGN | Design Therapeutics, Inc. | 557.68M | 1.66% | 372,379 | - |
| 211 | CRVS | Corvus Pharmaceuticals, Inc. | 556.38M | -3.25% | 1,296,544 | - |
| 212 | LBRX | LB Pharmaceuticals Inc | 541.40M | -0.46% | 288,942 | - |
| 213 | VOR | Vor Biopharma Inc. | 531.24M | -6.79% | 690,351 | - |
| 214 | NAGE | Niagen Bioscience, Inc. | 527.79M | -0.75% | 977,218 | 124.71M |
| 215 | ASMB | Assembly Biosciences, Inc. | 527.03M | -0.89% | 113,880 | 37.19M |
| 216 | ABSI | Absci Corporation | 518.78M | -3.36% | 1,779,221 | 2.82M |
| 217 | LENZ | LENZ Therapeutics, Inc. | 516.91M | -2.07% | 588,035 | 17.50M |
| 218 | PRTA | Prothena Corporation plc | 510.31M | -0.63% | 493,479 | 11.79M |
| 219 | AUTL | Autolus Therapeutics plc | 497.69M | 11.98% | 4,987,937 | 51.13M |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 496.54M | -0.56% | 1,297,451 | 84.39M |
| 221 | TENX | Tenax Therapeutics, Inc. | 494.15M | -3.87% | 45,614 | - |
| 222 | SLS | SELLAS Life Sciences Group, Inc. | 477.18M | 16.72% | 22,587,354 | - |
| 223 | ENTA | Enanta Pharmaceuticals, Inc. | 474.21M | -2.49% | 311,458 | 65.32M |
| 224 | BCYC | Bicycle Therapeutics plc | 470.31M | -0.59% | 289,085 | 28.34M |
| 225 | FBRX | Forte Biosciences, Inc. | 464.87M | -6.46% | 173,842 | - |
| 226 | NBP | NovaBridge Biosciences | 464.62M | -7.14% | 697,741 | - |
| 227 | DNA | Ginkgo Bioworks Holdings, Inc. | 464.35M | -2.74% | 795,817 | 180.61M |
| 228 | VTVT | vTv Therapeutics Inc. | 463.35M | -1.50% | 10,592 | 17.00K |
| 229 | OCGN | Ocugen, Inc. | 462.23M | 4.96% | 5,141,127 | 5.37M |
| 230 | BNTC | Benitec Biopharma Inc. | 456.80M | 2.98% | 199,584 | - |
| 231 | SLDB | Solid Biosciences Inc. | 443.31M | -2.57% | 839,432 | - |
| 232 | IMMP | Immutep Limited | 438.90M | -3.83% | 407,089 | 3.31M |
| 233 | FDMT | 4D Molecular Therapeutics, Inc. | 438.80M | -3.64% | 736,823 | 120.00K |
| 234 | MNPR | Monopar Therapeutics Inc. | 438.18M | -4.65% | 483,449 | - |
| 235 | CYBN | Cybin Inc. | 434.66M | 4.44% | 1,476,453 | - |
| 236 | ADCT | ADC Therapeutics SA | 433.57M | -0.28% | 562,024 | 75.21M |
| 237 | DRTS | Alpha Tau Medical Ltd. | 431.44M | -0.78% | 168,485 | - |
| 238 | DMAC | DiaMedica Therapeutics Inc. | 431.20M | 0.61% | 177,640 | - |
| 239 | IMRX | Immuneering Corporation | 430.04M | -1.04% | 1,101,848 | - |
| 240 | VNDA | Vanda Pharmaceuticals Inc. | 425.50M | 2.27% | 2,463,526 | 212.07M |
| 241 | LXRX | Lexicon Pharmaceuticals, Inc. | 425.18M | -4.88% | 1,543,801 | 70.86M |
| 242 | PEPG | PepGen Inc. | 420.05M | 5.16% | 549,849 | - |
| 243 | PRTC | PureTech Health plc | 416.61M | 1.61% | 624 | 6.39M |
| 244 | KYTX | Kyverna Therapeutics, Inc. | 415.63M | 0.96% | 1,215,160 | - |
| 245 | LCTX | Lineage Cell Therapeutics, Inc. | 394.99M | -1.21% | 947,394 | 10.82M |
| 246 | TECX | Tectonic Therapeutic, Inc. | 388.74M | -0.53% | 166,947 | - |
| 247 | ALT | Altimmune, Inc. | 383.98M | -4.66% | 4,515,820 | 20.00K |
| 248 | RCKT | Rocket Pharmaceuticals, Inc. | 376.61M | - | 1,012,904 | - |
| 249 | XFOR | X4 Pharmaceuticals, Inc. | 375.98M | -4.44% | 303,438 | 33.98M |
| 250 | EPRX | Eupraxia Pharmaceuticals Inc. | 371.04M | 2.38% | 271,962 | - |
| 251 | PALI | Palisade Bio, Inc. | 369.53M | 15.35% | 13,780,759 | - |
| 252 | TRDA | Entrada Therapeutics, Inc. | 366.86M | -1.73% | 196,303 | 61.52M |
| 253 | CLLS | Cellectis S.A. | 356.01M | 3.79% | 105,073 | 82.55M |
| 254 | CTNM | Contineum Therapeutics, Inc. | 353.08M | -2.51% | 358,146 | - |
| 255 | ZURA | Zura Bio Limited | 347.87M | 15.05% | 1,393,127 | - |
| 256 | AURA | Aura Biosciences, Inc. | 346.73M | -6.98% | 403,977 | - |
| 257 | GLSI | Greenwich LifeSciences, Inc. | 343.32M | 19.80% | 4,254,337 | - |
| 258 | LRMR | Larimar Therapeutics, Inc. | 338.94M | 0.76% | 540,586 | - |
| 259 | AVTX | Avalo Therapeutics, Inc. | 336.57M | 1.03% | 131,650 | 192.00K |
| 260 | RLMD | Relmada Therapeutics, Inc. | 326.33M | -1.33% | 406,355 | - |
| 261 | AVXL | Anavex Life Sciences Corp. | 326.12M | 0.27% | 1,713,987 | - |
| 262 | ACRS | Aclaris Therapeutics, Inc. | 326.12M | -0.66% | 428,857 | 15.74M |
| 263 | GUTS | Fractyl Health, Inc. | 324.80M | 4.41% | 1,939,437 | 3.00K |
| 264 | ACIU | AC Immune SA | 321.57M | 3.83% | 293,856 | 5.48M |
| 265 | CADL | Candel Therapeutics, Inc. | 318.41M | -3.49% | 429,205 | - |
| 266 | XOMA | XOMA Royalty Corporation | 312.67M | -3.11% | 253,114 | 47.11M |
| 267 | NGNE | Neurogene Inc. | 311.96M | 0.65% | 144,642 | 925.00K |
| 268 | ALDX | Aldeyra Therapeutics, Inc. | 311.04M | -2.64% | 418,150 | - |
| 269 | ALLO | Allogene Therapeutics, Inc. | 310.13M | - | 1,828,838 | 22.00K |
| 270 | PBYI | Puma Biotechnology, Inc. | 307.39M | -0.97% | 523,739 | 212.00M |
| 271 | NMRA | Neumora Therapeutics, Inc. | 302.49M | - | 668,869 | - |
| 272 | SLN | Silence Therapeutics plc | 298.05M | 1.77% | 233,748 | 25.83M |
| 273 | FHTX | Foghorn Therapeutics Inc. | 293.50M | -3.89% | 128,363 | 24.52M |
| 274 | AARD | Aardvark Therapeutics, Inc. | 293.18M | -1.36% | 171,228 | - |
| 275 | ABEO | Abeona Therapeutics Inc. | 291.01M | -1.47% | 886,481 | 400.00K |
| 276 | IMMX | Immix Biopharma, Inc. | 289.83M | -2.48% | 952,526 | - |
| 277 | TARA | Protara Therapeutics, Inc. | 287.23M | -3.42% | 420,357 | - |
| 278 | AVIR | Atea Pharmaceuticals, Inc. | 281.26M | -1.37% | 337,688 | - |
| 279 | CAMP | Camp4 Therapeutics Corporation | 280.82M | 0.50% | 65,792 | 3.80M |
| 280 | OABI | OmniAb, Inc. | 273.52M | -1.55% | 384,951 | 21.09M |
| 281 | IKT | Inhibikase Therapeutics, Inc. | 268.09M | -2.00% | 775,791 | 1.00 |
| 282 | GALT | Galectin Therapeutics Inc. | 263.05M | 0.74% | 283,815 | - |
| 283 | FENC | Fennec Pharmaceuticals Inc. | 262.64M | -4.94% | 193,133 | 38.79M |
| 284 | NAUT | Nautilus Biotechnology, Inc. | 245.03M | -2.02% | 138,761 | - |
| 285 | PRLD | Prelude Therapeutics Incorporated | 242.25M | 20.00% | 1,551,965 | 10.50M |
| 286 | HRTX | Heron Therapeutics, Inc. | 240.20M | 2.34% | 1,956,244 | 155.10M |
| 287 | MDWD | MediWound Ltd. | 239.25M | -0.69% | 74,895 | 20.93M |
| 288 | OBIO | Orchestra BioMed Holdings, Inc. | 237.72M | -2.55% | 187,290 | 2.82M |
| 289 | ACHV | Achieve Life Sciences, Inc. | 236.36M | -1.00% | 197,059 | - |
| 290 | CBIO | Crescent Biopharma, Inc. | 236.16M | -2.19% | 53,144 | - |
| 291 | ARMP | Armata Pharmaceuticals, Inc. | 231.55M | -3.34% | 14,734 | 5.05M |
| 292 | RZLT | Rezolute, Inc. | 225.33M | -8.99% | 5,544,907 | - |
| 293 | VYGR | Voyager Therapeutics, Inc. | 224.62M | -0.98% | 244,609 | 31.32M |
| 294 | STTK | Shattuck Labs, Inc. | 221.48M | 4.48% | 779,488 | 1.00M |
| 295 | CABA | Cabaletta Bio, Inc. | 219.48M | 4.11% | 1,331,258 | - |
| 296 | PRQR | ProQR Therapeutics N.V. | 215.43M | -5.76% | 684,480 | 18.86M |
| 297 | OVID | Ovid Therapeutics Inc. | 214.80M | -7.30% | 1,262,554 | 6.61M |
| 298 | MENS | Jyong Biotech Ltd. | 213.78M | -13.66% | 846,827 | - |
| 299 | CLYM | Climb Bio, Inc. | 211.99M | -9.94% | 619,604 | - |
| 300 | MIST | Milestone Pharmaceuticals Inc. | 207.23M | -1.92% | 2,910,116 | - |
| 301 | EDIT | Editas Medicine, Inc. | 205.00M | -3.23% | 2,002,923 | 46.38M |
| 302 | CRDF | Cardiff Oncology, Inc. | 198.71M | -6.94% | 1,016,946 | 501.00K |
| 303 | CCCC | C4 Therapeutics, Inc. | 196.74M | -4.25% | 889,629 | 30.11M |
| 304 | NVCT | Nuvectis Pharma, Inc. | 196.72M | -0.90% | 32,177 | - |
| 305 | SGMT | Sagimet Biosciences Inc. | 192.20M | -0.84% | 272,061 | - |
| 306 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.72M | 0.12% | 740,836 | 10.30M |
| 307 | HUMA | Humacyte, Inc. | 191.02M | -4.67% | 4,830,860 | 1.57M |
| 308 | QNCX | Quince Therapeutics, Inc. | 189.32M | -4.49% | 194,790 | - |
| 309 | SRZN | Surrozen, Inc. | 189.29M | -0.52% | 78,647 | 3.60M |
| 310 | TLSA | Tiziana Life Sciences Ltd | 184.18M | 4.73% | 189,487 | - |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 175.02M | - | 591,972 | 97.60M |
| 312 | SABS | SAB Biotherapeutics, Inc. | 173.77M | -3.44% | 112,050 | 114.70K |
| 313 | KLRS | Kalaris Therapeutics, Inc. | 170.75M | -2.32% | 101,284 | - |
| 314 | NTHI | NeOnc Technologies Holdings, Inc. | 168.26M | 0.82% | 50,661 | 59.99K |
| 315 | RANI | Rani Therapeutics Holdings, Inc. | 167.70M | -1.43% | 1,778,737 | 1.20M |
| 316 | IPHA | Innate Pharma S.A. | 167.40M | -2.86% | 31,725 | 14.84M |
| 317 | RNAC | Cartesian Therapeutics, Inc. | 167.20M | -3.74% | 91,662 | 1.09M |
| 318 | ALEC | Alector, Inc. | 165.91M | 4.83% | 1,575,491 | 69.05M |
| 319 | GNLX | Genelux Corporation | 164.77M | 0.23% | 91,329 | 8.00K |
| 320 | MOLN | Molecular Partners AG | 164.03M | 4.73% | 1,977 | 856.30K |
| 321 | CHRS | Coherus Oncology, Inc. | 161.97M | 0.75% | 715,250 | 277.73M |
| 322 | CRBU | Caribou Biosciences, Inc. | 154.22M | -2.94% | 1,105,315 | 9.30M |
| 323 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 152.49M | -1.20% | 222,979 | - |
| 324 | CNTB | Connect Biopharma Holdings Limited | 150.94M | 0.37% | 121,043 | 762.00K |
| 325 | CDXS | Codexis, Inc. | 148.13M | 0.61% | 2,239,160 | 52.93M |
| 326 | PLX | Protalix BioTherapeutics, Inc. | 143.95M | -1.10% | 639,858 | 61.84M |
| 327 | MRSN | Mersana Therapeutics, Inc. | 143.61M | -1.19% | 148,605 | 33.18M |
| 328 | BDTX | Black Diamond Therapeutics, Inc. | 141.87M | -3.86% | 721,288 | 70.00M |
| 329 | ELTX | Elicio Therapeutics, Inc. | 139.80M | -0.87% | 106,460 | - |
| 330 | ACOG | Alpha Cognition Inc. | 138.61M | 1.76% | 82,335 | 7.43M |
| 331 | CGEN | Compugen Ltd. | 137.50M | -4.55% | 291,355 | 6.90M |
| 332 | SGMO | Sangamo Therapeutics, Inc. | 137.49M | -3.86% | 5,731,280 | 32.88M |
| 333 | IRD | Opus Genetics, Inc. | 137.24M | -1.49% | 389,322 | 14.63M |
| 334 | ACTU | Actuate Therapeutics, Inc. | 136.21M | -9.36% | 97,694 | - |
| 335 | MCRB | Seres Therapeutics, Inc. | 134.97M | 1.84% | 104,520 | 351.00K |
| 336 | NKTX | Nkarta, Inc. | 131.40M | 0.54% | 558,300 | - |
| 337 | VRCA | Verrica Pharmaceuticals Inc. | 130.96M | 0.37% | 159,026 | 30.83M |
| 338 | ATRA | Atara Biotherapeutics, Inc. | 129.71M | 4.17% | 72,969 | 151.93M |
| 339 | SPRO | Spero Therapeutics, Inc. | 129.58M | -0.86% | 163,117 | 40.55M |
| 340 | UNCY | Unicycive Therapeutics, Inc. | 127.44M | -2.31% | 526,003 | - |
| 341 | OTLK | Outlook Therapeutics, Inc. | 126.95M | 8.79% | 5,795,816 | 1.41M |
| 342 | KPTI | Karyopharm Therapeutics Inc. | 125.15M | -1.34% | 158,548 | 142.53M |
| 343 | DWTX | Dogwood Therapeutics, Inc. | 124.86M | 3.19% | 72,900 | - |
| 344 | CGTX | Cognition Therapeutics, Inc. | 124.47M | -2.76% | 613,792 | - |
| 345 | SLGL | Sol-Gel Technologies Ltd. | 124.08M | 6.43% | 36,273 | 18.97M |
| 346 | WHWK | Whitehawk Therapeutics, Inc. | 122.06M | -3.00% | 80,116 | 14.38M |
| 347 | GANX | Gain Therapeutics, Inc. | 121.54M | 0.32% | 905,817 | - |
| 348 | ABOS | Acumen Pharmaceuticals, Inc. | 121.15M | -5.21% | 228,201 | - |
| 349 | TNYA | Tenaya Therapeutics, Inc. | 119.87M | -4.54% | 3,123,560 | - |
| 350 | INO | Inovio Pharmaceuticals, Inc. | 118.86M | -24.45% | 6,130,200 | 182.34K |
| 351 | ELDN | Eledon Pharmaceuticals, Inc. | 116.48M | -3.13% | 554,891 | - |
| 352 | COYA | Coya Therapeutics, Inc. | 116.13M | 1.46% | 221,407 | 3.99M |
| 353 | ORMP | Oramed Pharmaceuticals Inc. | 115.83M | -1.36% | 132,223 | 2.00M |
| 354 | FATE | Fate Therapeutics, Inc. | 115.06M | -0.25% | 1,082,516 | 7.14M |
| 355 | CNTX | Context Therapeutics Inc. | 111.17M | 7.08% | 502,432 | - |
| 356 | FBIO | Fortress Biotech, Inc. | 111.12M | -4.28% | 663,120 | 62.30M |
| 357 | RPTX | Repare Therapeutics Inc. | 110.36M | -0.39% | 610,969 | 11.87M |
| 358 | ARTV | Artiva Biotherapeutics, Inc. | 108.73M | 5.98% | 181,815 | 251.00K |
| 359 | AGEN | Agenus Inc. | 108.49M | -3.63% | 665,441 | 106.83M |
| 360 | ANIX | Anixa Biosciences, Inc. | 104.68M | -0.63% | 213,120 | - |
| 361 | DTIL | Precision BioSciences, Inc. | 103.51M | 1.65% | 293,887 | 698.00K |
| 362 | SEER | Seer, Inc. | 102.38M | -1.09% | 159,717 | 16.38M |
| 363 | MGNX | MacroGenics, Inc. | 101.21M | -0.62% | 566,427 | 127.63M |
| 364 | SAVA | Cassava Sciences, Inc. | 100.96M | -4.13% | 808,986 | - |
| 365 | THAR | Tharimmune, Inc. | 98.83M | 8.88% | 747,972 | - |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 98.26M | - | 517,515 | 26.87M |
| 367 | ONCY | Oncolytics Biotech Inc. | 97.43M | -4.89% | 853,824 | - |
| 368 | ETHZ | ETHZilla Corporation | 97.24M | -0.87% | 950,896 | 4.11M |
| 369 | EXOZ | eXoZymes, Inc. | 96.37M | - | 1,041 | -700.00 |
| 370 | CSBR | Champions Oncology, Inc. | 95.82M | -1.15% | 7,360 | 58.42M |
| 371 | STRO | Sutro Biopharma, Inc. | 94.57M | -3.39% | 101,388 | 105.65M |
| 372 | ANVS | Annovis Bio, Inc. | 92.76M | -2.78% | 286,967 | - |
| 373 | TTRX | Turn Therapeutics Inc. | 92.46M | 14.60% | 104,715 | - |
| 374 | VANI | Vivani Medical, Inc. | 91.19M | -1.57% | 242,860 | - |
| 375 | EQ | Equillium, Inc. | 89.51M | -2.00% | 1,748,832 | 4.39M |
| 376 | CBUS | Cibus, Inc. | 88.48M | -4.12% | 153,474 | 3.79M |
| 377 | SPRB | Spruce Biosciences, Inc. | 88.09M | -4.01% | 18,395 | 697.00K |
| 378 | IPSC | Century Therapeutics, Inc. | 87.31M | -7.83% | 1,209,281 | 113.34M |
| 379 | BMEA | Biomea Fusion, Inc. | 85.55M | -8.33% | 915,322 | - |
| 380 | ATOS | Atossa Therapeutics, Inc. | 85.07M | -0.05% | 1,060,359 | - |
| 381 | ADAG | Adagene Inc. | 84.36M | 0.56% | 56,962 | 103.20K |
| 382 | CALC | CalciMedica, Inc. | 84.30M | -6.10% | 40,166 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 83.96M | 5.80% | 8,372 | 7.41M |
| 384 | VXRT | Vaxart, Inc. | 83.85M | 1.16% | - | 148.20M |
| 385 | ENTX | Entera Bio Ltd. | 82.54M | 4.65% | 146,319 | 124.00K |
| 386 | ACET | Adicet Bio, Inc. | 79.57M | -5.37% | 2,690,770 | - |
| 387 | COEP | Coeptis Therapeutics Holdings, Inc. | 79.46M | 1.57% | 31,206 | 501.00K |
| 388 | HYFT | MindWalk Holdings Corp. | 77.04M | -2.94% | 227,668 | 19.02M |
| 389 | PLRX | Pliant Therapeutics, Inc. | 75.58M | 1.65% | 1,104,006 | - |
| 390 | KRRO | Korro Bio, Inc. | 75.43M | -1.35% | 188,206 | 7.37M |
| 391 | PSTV | Plus Therapeutics, Inc. | 75.26M | -5.57% | 2,810,121 | 5.26M |
| 392 | BYSI | BeyondSpring Inc. | 74.84M | -1.09% | 59,925 | 1.88M |
| 393 | ACRV | Acrivon Therapeutics, Inc. | 74.47M | -3.28% | 565,499 | - |
| 394 | ATYR | aTyr Pharma, Inc. | 73.35M | 0.78% | 2,575,379 | 190.00K |
| 395 | NRXP | NRx Pharmaceuticals, Inc. | 73.05M | 1.56% | 498,368 | 242.00K |
| 396 | PYPD | PolyPid Ltd. | 73.03M | 7.86% | 183,270 | - |
| 397 | XBIT | XBiotech Inc. | 73.02M | -3.04% | 58,857 | - |
| 398 | TIL | Instil Bio, Inc. | 72.97M | -4.86% | 71,989 | - |
| 399 | CRVO | CervoMed Inc. | 72.36M | -3.22% | 121,978 | 6.16M |
| 400 | OKYO | OKYO Pharma Limited | 71.84M | -4.02% | 67,694 | - |
| 401 | TVGN | Tevogen Bio Holdings Inc. | 69.24M | -8.46% | 765,012 | - |
| 402 | IFRX | InflaRx N.V. | 69.10M | -7.27% | 830,400 | 73.73K |
| 403 | ALXO | ALX Oncology Holdings Inc. | 68.31M | -5.26% | 95,662 | - |
| 404 | IMA | ImageneBio, Inc. | 68.27M | 10.52% | 352,463 | 800.00K |
| 405 | NTRB | Nutriband Inc. | 67.71M | 16.04% | 799,855 | 2.28M |
| 406 | ANL | Adlai Nortye Ltd. | 66.42M | 9.76% | 23,603,221 | -1.35M |
| 407 | PYXS | Pyxis Oncology, Inc. | 66.00M | -4.50% | 1,731,006 | 2.82M |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 64.92M | -1.61% | 157,830 | - |
| 409 | MNOV | MediciNova, Inc. | 62.91M | 0.79% | 68,525 | 257.92K |
| 410 | IMUX | Immunic, Inc. | 62.70M | -7.13% | 2,123,272 | - |
| 411 | RADX | Radiopharm Theranostics Limited | 61.81M | -2.36% | 69,968 | 8.20M |
| 412 | MGX | Metagenomi, Inc. | 61.20M | -4.12% | 515,967 | 30.91M |
| 413 | ALGS | Aligos Therapeutics, Inc. | 59.38M | -4.55% | 57,630 | 2.65M |
| 414 | TCRX | TScan Therapeutics, Inc. | 58.45M | -2.83% | 575,987 | 8.42M |
| 415 | ATHE | Alterity Therapeutics Limited | 58.36M | -4.73% | 17,350 | 3.57M |
| 416 | INKT | MiNK Therapeutics, Inc. | 56.89M | 1.42% | 28,285 | - |
| 417 | ESLA | Estrella Immunopharma, Inc. | 55.52M | -4.55% | 41,266 | - |
| 418 | ICCC | ImmuCell Corporation | 55.27M | -0.16% | 58,276 | 27.77M |
| 419 | ABVC | ABVC BioPharma, Inc. | 54.45M | -4.94% | 73,821 | 797.92K |
| 420 | MAIA | MAIA Biotechnology, Inc. | 53.70M | -7.64% | 879,566 | - |
| 421 | GRCE | Grace Therapeutics, Inc. | 52.46M | -0.29% | 40,127 | - |
| 422 | OSTX | OS Therapies Incorporated | 52.12M | -1.99% | 252,540 | - |
| 423 | JSPR | Jasper Therapeutics, Inc. | 49.25M | - | 474,705 | - |
| 424 | LITS | Lite Strategy, Inc. | 48.92M | -1.48% | 875,351 | - |
| 425 | IOBT | IO Biotech, Inc. | 48.65M | -8.50% | 387,528 | - |
| 426 | IBO | Impact BioMedical Inc. | 48.07M | -7.77% | 87,477 | 25.00K |
| 427 | HURA | TuHURA Biosciences, Inc. | 47.86M | -0.96% | 313,687 | - |
| 428 | GLTO | Galecto, Inc. | 47.23M | -13.27% | 82,074 | - |
| 429 | PTN | Palatin Technologies, Inc. | 47.18M | 6.50% | 29,150 | 8.85M |
| 430 | KZR | Kezar Life Sciences, Inc. | 46.43M | - | 5,587 | - |
| 431 | BCAB | BioAtla, Inc. | 46.27M | -6.11% | 1,731,298 | 11.00M |
| 432 | NXTC | NextCure, Inc. | 46.24M | 3.29% | 20,756 | - |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | -8.90% | 587,082 | - |
| 434 | MREO | Mereo BioPharma Group plc | 45.42M | -87.65% | 240,145,129 | 500.00K |
| 435 | APLM | Apollomics, Inc. | 44.85M | 4.50% | 29,477 | 6.93M |
| 436 | NRXS | NeurAxis, Inc. | 44.74M | 7.14% | 382,824 | 3.36M |
| 437 | PDSB | PDS Biotechnology Corporation | 44.46M | -10.15% | 776,681 | - |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 44.30M | -6.58% | 170,422 | 90.00K |
| 439 | INMB | INmune Bio, Inc. | 44.13M | -4.05% | 371,211 | 50.00K |
| 440 | CVM | CEL-SCI Corporation | 41.60M | 10.19% | 79,644 | - |
| 441 | IBIO | iBio, Inc. | 41.60M | -2.12% | 1,729,745 | 500.00K |
| 442 | EVAX | Evaxion A/S | 40.95M | -4.29% | 99,461 | 7.65M |
| 443 | ANEB | Anebulo Pharmaceuticals, Inc. | 40.83M | -11.28% | 239,511 | - |
| 444 | TVRD | Tvardi Therapeutics, Inc. | 40.62M | 4.59% | 254,715 | - |
| 445 | QTTB | Q32 Bio Inc. | 39.37M | - | 105,987 | - |
| 446 | LTRN | Lantern Pharma Inc. | 38.14M | -2.01% | 55,478 | - |
| 447 | GBIO | Generation Bio Co. | 38.00M | 0.71% | 61,421 | 15.27M |
| 448 | JUNS | Jupiter Neurosciences, Inc. | 37.87M | -3.51% | 89,185 | - |
| 449 | OKUR | OnKure Therapeutics, Inc. | 36.44M | -3.93% | 94,686 | - |
| 450 | FGEN | FibroGen, Inc. | 35.52M | -1.35% | 28,905 | 8.30M |
| 451 | VERU | Veru Inc. | 35.47M | -7.92% | 221,305 | 16.89M |
| 452 | PASG | Passage Bio, Inc. | 35.22M | 2.03% | 42,099 | - |
| 453 | LPCN | Lipocine Inc. | 34.92M | 20.27% | 767,646 | 4.32M |
| 454 | XCUR | Exicure, Inc. | 34.87M | -8.68% | 113,173 | 500.00K |
| 455 | XLO | Xilio Therapeutics, Inc. | 34.13M | -1.80% | 407,165 | 31.80M |
| 456 | BTAI | BioXcel Therapeutics, Inc. | 34.12M | -6.02% | 778,851 | 752.00K |
| 457 | CELU | Celularity Inc. | 33.99M | -10.45% | 184,086 | 40.58M |
| 458 | QNTM | Quantum BioPharma Ltd. | 33.49M | -3.13% | 54,724 | - |
| 459 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 33.39M | -5.44% | 9,604,574 | - |
| 460 | GNTA | Genenta Science S.p.A. | 32.81M | -4.11% | 70,901 | - |
| 461 | DYAI | Dyadic International, Inc. | 32.20M | -6.51% | 136,638 | 3.34M |
| 462 | HOWL | Werewolf Therapeutics, Inc. | 30.15M | -5.06% | 1,846,663 | 1.14M |
| 463 | RNTX | Rein Therapeutics Inc. | 29.97M | -8.06% | 315,127 | - |
| 464 | ANTX | AN2 Therapeutics, Inc. | 29.87M | -4.39% | 48,370 | - |
| 465 | RNXT | RenovoRx, Inc. | 29.86M | -4.67% | 386,053 | 928.00K |
| 466 | RLYB | Rallybio Corporation | 29.74M | 2.39% | 178,356 | 674.00K |
| 467 | ATHA | Athira Pharma, Inc. | 29.58M | 0.27% | 198,570 | - |
| 468 | HYPD | Hyperion DeFi, Inc. | 28.60M | -8.85% | 273,950 | 345.32K |
| 469 | NERV | Minerva Neurosciences, Inc. | 28.60M | -2.39% | 38,849 | - |
| 470 | DARE | Daré Bioscience, Inc. | 28.58M | -6.98% | 251,120 | -57.13K |
| 471 | BRNS | Barinthus Biotherapeutics plc | 28.18M | -2.00% | 84,476 | 14.97M |
| 472 | PLUR | Pluri Inc. | 27.95M | -2.89% | 21,358 | 1.33M |
| 473 | SNTI | Senti Biosciences, Inc. | 27.87M | - | 501,583 | - |
| 474 | IGC | IGC Pharma, Inc. | 27.61M | -0.87% | 341,506 | 1.11M |
| 475 | CING | Cingulate Inc. | 27.57M | -2.39% | 75,256 | - |
| 476 | BOLD | Boundless Bio, Inc. | 26.86M | - | 45,885 | - |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 26.19M | -8.96% | 3,223,292 | 721.00K |
| 478 | KTTA | Pasithea Therapeutics Corp. | 25.53M | 1.79% | 244,533 | - |
| 479 | MRKR | Marker Therapeutics, Inc. | 25.34M | 5.92% | 430,703 | 4.69M |
| 480 | SKYE | Skye Bioscience, Inc. | 25.00M | -2.50% | 806,261 | - |
| 481 | SER | Serina Therapeutics, Inc. | 24.53M | -13.53% | 30,998 | 116.00K |
| 482 | KLTO | Klotho Neurosciences, Inc. | 23.40M | -6.92% | 1,122,845 | - |
| 483 | LIXT | Lixte Biotechnology Holdings, Inc. | 22.36M | -3.69% | 50,665 | - |
| 484 | INTS | Intensity Therapeutics, Inc. | 22.11M | -6.26% | 1,741,976 | - |
| 485 | LNAI | Lunai Bioworks Inc. | 21.93M | -3.59% | 163,125 | - |
| 486 | NNVC | NanoViricides, Inc. | 21.87M | -5.88% | 312,444 | - |
| 487 | CUE | Cue Biopharma, Inc. | 21.81M | -14.72% | 3,066,369 | 7.10M |
| 488 | NEUP | Neuphoria Therapeutics Inc. | 20.27M | 1.34% | 60,632 | 15.65M |
| 489 | MTVA | MetaVia Inc. | 19.81M | -2.07% | 18,145 | - |
| 490 | NRSN | NeuroSense Therapeutics Ltd. | 19.03M | -5.00% | 444,454 | - |
| 491 | VYNE | VYNE Therapeutics Inc. | 18.69M | -4.49% | 1,499,831 | 524.00K |
| 492 | CLGN | CollPlant Biotechnologies Ltd. | 18.40M | -5.88% | 127,178 | 2.48M |
| 493 | ENLV | Enlivex Therapeutics Ltd. | 18.10M | -0.37% | 422,337 | - |
| 494 | LIMN | Liminatus Pharma, Inc. | 18.03M | 2.92% | 172,334 | - |
| 495 | LSTA | Lisata Therapeutics, Inc. | 17.20M | -1.02% | 59,759 | 1.07M |
| 496 | CTXR | Citius Pharmaceuticals, Inc. | 17.16M | -1.69% | 1,123,779 | - |
| 497 | GDTC | CytoMed Therapeutics Limited | 16.62M | -5.88% | 23,143 | 573.19K |
| 498 | ALLR | Allarity Therapeutics, Inc. | 16.59M | -1.87% | 106,044 | - |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 16.16M | -6.75% | 54,756 | - |
| 500 | CANF | Can-Fite BioPharma Ltd. | 16.08M | -19.82% | 6,430,277 | 560.00K |
| 501 | CASI | CASI Pharmaceuticals, Inc. | 15.88M | -2.12% | 45,691 | 26.85M |
| 502 | PMN | ProMIS Neurosciences, Inc. | 15.85M | -3.85% | 16,763 | - |
| 503 | PLRZ | Polyrizon Ltd. | 15.85M | -1.35% | 82,200 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 15.67M | - | 128,766 | - |
| 505 | BCTX | BriaCell Therapeutics Corp. | 15.48M | -8.91% | 120,386 | - |
| 506 | FBLG | FibroBiologics, Inc. | 15.32M | 0.40% | 1,164,186 | - |
| 507 | ITRM | Iterum Therapeutics plc | 15.26M | -4.21% | 890,653 | 390.00K |
| 508 | APLT | Applied Therapeutics, Inc. | 15.15M | -7.81% | 12,248,637 | 1.00M |
| 509 | KAPA | Kairos Pharma, Ltd. | 14.74M | - | 205,208 | - |
| 510 | OSRH | OSR Holdings, Inc. | 14.72M | -9.53% | 685,043 | -90.52K |
| 511 | NCNA | NuCana plc | 14.40M | 4.53% | 135,743 | - |
| 512 | TPST | Tempest Therapeutics, Inc. | 14.39M | -2.34% | 78,811 | - |
| 513 | SNGX | Soligenix, Inc. | 14.22M | 2.92% | 241,951 | 2.34K |
| 514 | LEXX | Lexaria Bioscience Corp. | 13.94M | 5.48% | 780,629 | 705.92K |
| 515 | SYBX | Synlogic, Inc. | 13.57M | -4.92% | 5,341 | 8.00K |
| 516 | COCP | Cocrystal Pharma, Inc. | 13.50M | 0.73% | 161,465 | - |
| 517 | CRIS | Curis, Inc. | 13.45M | -1.89% | 102,163 | 11.65M |
| 518 | BLRX | BioLineRx Ltd. | 13.07M | 0.69% | 61,978 | 12.74M |
| 519 | BCDA | BioCardia, Inc. | 13.05M | -3.15% | 611,177 | 3.00K |
| 520 | EDSA | Edesa Biotech, Inc. | 12.33M | 2.78% | 137,890 | - |
| 521 | QNRX | Quoin Pharmaceuticals, Ltd. | 12.12M | 3.29% | 9,052 | - |
| 522 | AEON | AEON Biopharma, Inc. | 12.08M | - | 90,963 | - |
| 523 | ABP | Abpro Holdings, Inc. | 11.72M | -6.20% | 17,906 | 183.00K |
| 524 | ASBP | Aspire Biopharma Holdings, Inc. | 11.61M | - | 10,172,084 | 1.94K |
| 525 | PHIO | Phio Pharmaceuticals Corp. | 11.41M | -1.85% | 233,648 | - |
| 526 | KZIA | Kazia Therapeutics Limited | 11.34M | -18.36% | 305,509 | 1.20M |
| 527 | GRDX | GridAI Technologies Corp. | 11.26M | 12.42% | 176,231 | - |
| 528 | SNSE | Sensei Biotherapeutics, Inc. | 11.19M | -1.39% | 6,746 | - |
| 529 | IMNN | Imunon, Inc. | 11.15M | 15.24% | 298,907 | - |
| 530 | LGVN | Longeveron Inc. | 11.03M | -2.91% | 437,271 | 1.44M |
| 531 | CLRB | Cellectar Biosciences, Inc. | 10.85M | - | 46,716 | - |
| 532 | MBRX | Moleculin Biotech, Inc. | 10.60M | -10.18% | 518,936 | - |
| 533 | CMMB | Chemomab Therapeutics Ltd. | 10.40M | -6.11% | 107,560 | - |
| 534 | BOLT | Bolt Biotherapeutics, Inc. | 10.33M | 0.94% | 22,749 | 5.20M |
| 535 | GTBP | GT Biopharma, Inc. | 9.79M | 10.54% | 4,401,248 | - |
| 536 | BRTX | BioRestorative Therapies, Inc. | 9.76M | -1.79% | 98,278 | 383.40K |
| 537 | NCEL | NewcelX Ltd. | 9.75M | -14.40% | 90,193 | - |
| 538 | AKTX | Akari Therapeutics, Plc | 9.35M | -1.58% | 734,299 | - |
| 539 | INAB | IN8bio, Inc. | 9.32M | -9.87% | 242,422 | - |
| 540 | BIVI | BioVie Inc. | 9.27M | 1.65% | 218,707 | - |
| 541 | APVO | Aptevo Therapeutics Inc. | 9.27M | -9.42% | 2,155,493 | - |
| 542 | ERNA | Ernexa Therapeutics Inc. | 9.18M | -3.31% | 100,405 | 1,000.00 |
| 543 | TRAW | Traws Pharma, Inc. | 9.03M | -3.42% | 149,921 | 2.85M |
| 544 | APM | Aptorum Group Limited | 8.80M | -5.26% | 44,313 | - |
| 545 | EVGN | Evogene Ltd. | 8.78M | -6.24% | 87,650 | 8.02M |
| 546 | CLDI | Calidi Biotherapeutics, Inc. | 8.71M | -4.03% | 168,372 | - |
| 547 | ICU | SeaStar Medical Holding Corporation | 8.37M | -9.29% | 842,811 | 881.00K |
| 548 | ADXN | Addex Therapeutics Ltd | 8.23M | -3.63% | 3,610 | 198.82K |
| 549 | PULM | Pulmatrix, Inc. | 8.11M | -5.13% | 33,255 | 3.00K |
| 550 | IMRN | Immuron Limited | 7.84M | -4.96% | 27,849 | 4.78M |
| 551 | PPCB | Propanc Biopharma, Inc. | 7.83M | - | 103,589 | - |
| 552 | PCSA | Processa Pharmaceuticals, Inc. | 7.73M | -13.01% | 221,844 | - |
| 553 | TCRT | Alaunos Therapeutics, Inc. | 7.63M | 5.88% | 28,416 | 6.00K |
| 554 | ALZN | Alzamend Neuro, Inc. | 7.41M | -3.47% | 63,203 | - |
| 555 | PMCB | PharmaCyte Biotech, Inc. | 7.16M | -0.51% | 515,329 | - |
| 556 | BGMS | Bio Green Med Solution, Inc. | 7.11M | -2.03% | 30,440 | 81.00K |
| 557 | MBIO | Mustang Bio, Inc. | 7.02M | -5.69% | 171,187 | - |
| 558 | KPRX | Kiora Pharmaceuticals, Inc. | 7.01M | -3.05% | 58,218 | 20.00K |
| 559 | PPBT | Purple Biotech Ltd | 7.00M | -4.02% | 214,251 | - |
| 560 | CELZ | Creative Medical Technology Holdings, Inc. | 6.95M | -10.48% | 410,508 | 6.00K |
| 561 | XTLB | XTL Biopharmaceuticals Ltd. | 6.64M | -8.89% | 71,151 | 451.00K |
| 562 | TOVX | Theriva Biologics, Inc. | 6.61M | 2.40% | 125,867,542 | - |
| 563 | SLXN | Silexion Therapeutics Corp | 6.50M | -9.21% | 53,549 | - |
| 564 | KALA | KALA BIO, Inc. | 6.24M | -10.58% | 941,515 | - |
| 565 | ADIL | Adial Pharmaceuticals, Inc. | 6.17M | -0.47% | 565,503 | - |
| 566 | ACXP | Acurx Pharmaceuticals, Inc. | 6.15M | -7.52% | 72,504 | - |
| 567 | LYRA | Lyra Therapeutics, Inc. | 6.05M | -5.01% | 48,870 | 600.00K |
| 568 | RNAZ | TransCode Therapeutics, Inc. | 5.91M | -7.47% | 21,596 | - |
| 569 | APRE | Aprea Therapeutics, Inc. | 5.81M | -6.10% | 62,289 | 488.24K |
| 570 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.73M | -5.71% | 34,780 | 15.78K |
| 571 | REVB | Revelation Biosciences, Inc. | 5.22M | 2.53% | 131,339 | - |
| 572 | GOVX | GeoVax Labs, Inc. | 5.06M | -5.97% | 1,861,094 | 3.35M |
| 573 | VIVS | VivoSim Labs, Inc. | 4.93M | -5.97% | 25,067 | 140.00K |
| 574 | INDP | Indaptus Therapeutics, Inc. | 4.76M | 6.67% | 4,982,529 | - |
| 575 | JAGX | Jaguar Health, Inc. | 4.67M | -5.50% | 283,847 | 11.79M |
| 576 | XBIO | Xenetic Biosciences, Inc. | 4.65M | -2.40% | 38,137 | 2.86M |
| 577 | CYCN | Cyclerion Therapeutics, Inc. | 4.57M | -11.11% | 34,002 | 2.86M |
| 578 | SPRC | SciSparc Ltd. | 4.49M | -6.80% | 410,212 | 1.31M |
| 579 | SILO | Silo Pharma, Inc. | 4.45M | -8.26% | 218,361 | 72.10K |
| 580 | GLMD | Galmed Pharmaceuticals Ltd. | 4.35M | -8.24% | 191,843 | - |
| 581 | XRTX | XORTX Therapeutics Inc. | 4.11M | 7.17% | 89,640 | - |
| 582 | GNPX | Genprex, Inc. | 4.08M | -1.68% | 324,788 | - |
| 583 | MTNB | Matinas BioPharma Holdings, Inc. | 3.84M | -3.15% | 51,158 | - |
| 584 | ENVB | Enveric Biosciences, Inc. | 3.81M | -9.49% | 223,756 | - |
| 585 | SLRX | Salarius Pharmaceuticals, Inc. | 3.75M | -2.63% | 196,853 | - |
| 586 | ENSC | Ensysce Biosciences, Inc. | 3.67M | -8.18% | 204,134 | 4.49M |
| 587 | OGEN | Oragenics, Inc. | 3.42M | -4.35% | 74,058 | - |
| 588 | HCWB | HCW Biologics Inc. | 3.38M | -11.97% | 44,471 | 422.03K |
| 589 | CNSP | CNS Pharmaceuticals, Inc. | 3.29M | -13.94% | 28,889 | - |
| 590 | PHGE | BiomX Inc. | 3.05M | 3.63% | 95,843 | - |
| 591 | AZTR | Azitra, Inc. | 2.95M | -8.80% | 720,196 | 7.50K |
| 592 | CMND | Clearmind Medicine Inc. | 2.92M | -11.76% | 114,466 | - |
| 593 | PTIX | Protagenic Therapeutics, Inc. | 2.88M | 12.45% | 59,674 | - |
| 594 | GRI | GRI Bio, Inc. | 2.51M | -10.18% | 9,323,894 | - |
| 595 | ARTL | Artelo Biosciences, Inc. | 2.50M | -16.78% | 126,174 | - |
| 596 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.34M | -20.55% | 764,131 | 1.36M |
| 597 | CDT | CDT Equity Inc. | 2.31M | -0.70% | 65,381 | - |
| 598 | ONCO | Onconetix, Inc. | 2.24M | 0.70% | 42,091 | 1.22M |
| 599 | VRAX | Virax Biolabs Group Limited | 2.15M | -8.52% | 204,274 | 2.99K |
| 600 | SCNI | Scinai Immunotherapeutics Ltd. | 2.08M | -7.32% | 114,854 | 1.15M |
| 601 | DRMA | Dermata Therapeutics, Inc. | 1.91M | - | 2,918,442 | - |
| 602 | ADTX | Aditxt, Inc. | 1.83M | -8.04% | 394,113 | 5.95K |
| 603 | PBM | Psyence Biomedical Ltd. | 1.65M | -5.43% | 237,857 | - |
| 604 | BDRX | Biodexa Pharmaceuticals Plc | 1.44M | -11.79% | 280,200 | 104.90K |
| 605 | ELAB | PMGC Holdings Inc. | 1.04M | -9.68% | 267,959 | 285.95K |
| 606 | MLEC | Moolec Science SA | 1.02M | 5.41% | 1,330,139 | 7.83M |